Verrica Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director PRYGOCKI MARK A SR
Verrica Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Nguyen Diem
Verrica Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ballaron Craig
Verrica Pharmaceuticals | 8-K: Current report
Verrica Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Verrica Pharmaceuticals | 10-Q: Quarterly report
Verrica Pharmaceuticals | 8-K: Verrica Pharmaceuticals Reports First Quarter 2024 Financial Results
Verrica Pharmaceuticals | ARS: Annual Report to Security Holders
Verrica Pharmaceuticals | DEFA14A: Others
Verrica Pharmaceuticals | DEF 14A: Definitive information statements
Verrica Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Hayes Christopher G.
Verrica Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Goldenberg Gary
Verrica Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kohler Terry
Verrica Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer White Ted
Verrica Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bonaccorso Joe
Verrica Pharmaceuticals | 10-K: Annual report
Verrica Pharmaceuticals | 8-K: Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results
Verrica Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(16.9%),Joseph Edelman(16.9%), etc.
Verrica Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Avoro Capital Advisors LLC(9.99%),Behzad Aghazadeh(9.99%)
Verrica Pharmaceuticals | 8-K: Current report
No Data